GlassScriptPhysician profile
Wadie Shukri David
NPI 1740868272
$3,985.16
in general payments reported to CMS, 2019-2025
25 companies · $2,695 in 2025
The $2,695 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,290 · 2025: $2,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,826 · Education: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,825.99 |
| Education | $159.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $574.70 | 2024-2025 | Cardiomems, Ensite, Aveir |
| Abiomed | $436.09 | 2025 | |
| Chiesi USA, INC. | $394.85 | 2024-2025 | Kengreal, Cleviprex |
| Kestra Medical Technology Services, INC. | $381.84 | 2024-2025 | Assure Wcd |
| Medtronic, INC. | $337.96 | 2024-2025 | Symplicity G3, Corevalve Evolut R, In.Pact Admiral |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $262.69 | 2024 | Lifevest |
| Pfizer INC. | $247.15 | 2024-2025 | |
| Amgen INC. | $244.70 | 2024-2025 | Repatha, Repatha |
| Inari Medical, INC. | $179.73 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $170.60 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $152.80 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $129.68 | 2024-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $96.80 | 2025 | Wainua |
| Novartis Pharmaceuticals Corporation | $76.46 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.32 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.97 | 2025 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $37.11 | 2024 | Arcalyst |
| United Therapeutics Corporation | $33.97 | 2024 | Tyvaso |
| Teleflex LLC | $33.15 | 2024-2025 | Turnpike |
| Reflow Medical INC | $23.71 | 2025 | |
| Heartflow, INC. | $20.58 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.26 | 2025 | Onpattro |
| Scpharmaceuticals INC. | $18.38 | 2025 | |
| Ge Healthcare | $18.17 | 2025 | |
| Inspiremd LTD | $14.49 | 2025 | Cguard Prime Carotid Stent System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wadie David listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.